Clinical trial
Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney…
NCT00481481 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00481481 |
|---|---|
| Title | Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects |
| Official title | A Multicenter, Single-arm, Open, Conversion Study From a Cyclosporine (CyA) Based Immunosuppressive Regimen to a Tacrolimus Modified Release, FK506E (MR4), Based Immunosuppressive Regimen in Kidney Transplant Subjects (CONCERTO: Converting Cyclosporine to FK506E (MR4) in Renal Transplantation) |
| Acronym | CONCERTO |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Transplantation |
| Intervention type | Drug |
| Interventions | tacrolimus |
| Enrollment | 346 |
| Start date | Apr 1, 2007 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Jun 1, 2007 |
| Last update posted | Jul 18, 2014 |
| Countries | Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Poland, Spain, Sweden and 1 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: